Indian call to strengthen system for pediatric cancer treatment

17 February 2020

The Council for Healthcare and Pharma, headquartered in New Delhi, on Saturday cited the urgent need to strengthen the system for the treatment of cancers in children, in India.

Speaking on the occasion of the International Childhood Cancer Day, Dr Gurpreet Sandhu, president, Council for Healthcare and Pharma, said: "Cancer in Children from birth to the age of 18 is rearing its head as a huge problem. The irony is that if it were to be detected and treated early, children with cancer would have the highest chances of survival and recovery. Unfortunately, this is not the case as our systems to deal with pediatric cancer are woefully inadequate, leading to a high mortality rate, among children, on account of the disease."

The International Childhood Cancer Day is a global campaign to raise awareness about childhood cancer, and to express support for children and adolescents with cancer, the survivors and their families.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK